Rocket Doctor Ai Inc AIRDF

$MRNA $NVAX $AIRDF

$MRNA and $NVAX are drawing fresh attention, but the bigger story is how healthcare companies are extending their reach beyond a single product. We look at mRNA, vaccine commercialization and telehealth access through $MRNA, $NVAX and $AIRDF https://www.secfilings.com/news/healthcare-s-next-challenge-is-access-as-mrna-nvax-and-aidr-expand-their-reach

$MRNA $AIRDF Healthcare’s Next Challenge Is Access as MRNA, NVAX and AIDR Expand Their Reach

$AIRDF $NVAX

Healthcare innovation is about more than developing new treatments—it’s also about making sure they reach patients. Our latest SECFilings article looks at how $MRNA, $NVAX and $AIRDF are expanding access through new therapies, global commercialization and virtual care. https://www.secfilings.com/news/healthcare-s-next-challenge-is-access-as-mrna-nvax-and-aidr-expand-their-reach

Rocket Doctor AI Inc. (CSE: AIDR | OTC: $AIRDF | FRA: 939) will present on October 7, 2026 at the National Investment Banking Association (NIBA) 153rd Investment Conference at The Westin Fort Lauderdale Beach Resort in Fort Lauderdale, Florida. The conference runs October 6-7, with company presentations on October 7 and one-on-one meetings with the presenting companies that afternoon. Rocket Doctor AI Inc. is a B2i Digital Featured Company. See the company’s in-depth profile at: https://b2idigital.com/rocket-doctor-inc-1 Rocket Doctor AI Inc. delivers physician-guided, AI-powered solutions built to make high-quality healthcare accessible throughout the entire patient journey. A cornerstone of its proprietary technology is the Global Library of Medicine (GLM), a clinically validated decision support system developed with input from hundreds of physicians worldwide, alongside a digital health platform and marketplace that has helped more than 350 physicians support over 800,000 patient visits. Since 1982, NIBA has been serving the micro-cap and small-cap investment community. See the conference details and presenting companies: https://b2idigital.com/niba-153rd-investment-conference Register to attend: https://nibanet.org/attendee-registration-and-information/ B2i Digital, The Capital Markets Matchmaker℠, carries each presenting company's story From Marketing to Meetings℠, across its media network with a combined monthly audience of more than 330 million and its own community of 1.7 million+ investors and market participants. Discover more Featured Companies, Featured Experts, and upcoming Featured Conferences at b2idigital.com. B2i Digital is not a broker-dealer or investment adviser. This post is informational and not an offer or solicitation regarding any security. See the complete Disclosure at https://b2idigital.com/disclaimer. $LFMD, $TALK, $CLOV, $IHF

AI is moving beyond software and into real-world infrastructure and services. Our latest SECFilings Market Movers looks at how $APLD, $RIVN and $AIRDF are putting advanced computing to work across AI data centers, next-generation vehicles and healthcare delivery. https://www.secfilings.com/news/ai-moves-into-the-physical-world-as-apld-rivn-and-aidr-turn-computing-into-real-world-services

Rocket Doctor AI Inc. (CSE: AIDR, OTC: $AIRDF , Frankfurt: 939) said in an October 1 release that Dr. William Cherniak, Founder and CEO of its wholly owned subsidiary Rocket Doctor Inc., will present live at the 2026 CANTech Letter Conference in Toronto on Thursday, October 8, 2026. Dr. Cherniak will use the session to give attendees an overview of the company's platform, solutions, recent milestones and growth strategy. Rocket Doctor AI Inc. is a B2i Digital Featured Company. See the company's in-depth profile at: https://b2idigital.com/rocket-doctor-inc-1 The session will put Rocket Doctor AI before an annual Toronto conference that attracts a broad audience of investors: • The presentation runs from 4:00 to 4:30 p.m. ET in Track 2 of the conference in Toronto, Ontario • The conference brings together innovative Canadian companies across technology, healthcare, AI, cybersecurity, fintech and diversified industries • Its audience includes institutional investors and retail tech-focused investors seeking exposure to emerging Canadian investment ideas • Event details and registration are available at conference.cantechletter.com Regarding the conference and his presentation, Dr. William Cherniak, Founder and CEO of Rocket Doctor Inc., commented: "CANTech brings together Canada’s most engaged technology investors and operators. I am excited to share how Rocket Doctor AI is deploying clinician-led, pragmatic AI platforms to streamline workflows, reduce administrative friction, and ultimately improve patient access and outcomes." Read the full release: https://www.globenewswire.com/news-release/2026/10/01/3372842/0/en/rocket-doctor-ai-to-present-at-the-2026-cantech-letter-conference-in-toronto.html Rocket Doctor AI Inc. delivers physician-guided, AI-powered solutions built to make high-quality healthcare accessible throughout the entire patient journey. A cornerstone of its proprietary technology is the Global Library of Medicine (GLM), a clinically validated decision support system developed with input from hundreds of physicians worldwide, alongside a digital health platform and marketplace that has helped more than 350 physicians support over 800,000 patient visits. Discover more Featured Companies, Featured Experts, and upcoming Featured Conferences at b2idigital.com. B2i Digital is not a broker-dealer or investment adviser. This post is informational and not an offer or solicitation regarding any security. See the complete Disclosure at https://b2idigital.com/disclaimer. $LFMD, $TALK, $CLOV, $IHF